We conducted the present study to address the questions above, aiming to establish the pharmacological mechanisms of action of JPH203 as a novel anti‐cancer agent and further validate the clinical potential of LAT1 as a therapeutic target in cancer cells. Here, SLC7A5 is linked to cancer.